KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Analyst Ratings

NASDAQ:KMTS • BMG524411052

26.92 USD
-0.54 (-1.97%)
At close: Feb 13, 2026
26.92 USD
0 (0%)
After Hours: 2/13/2026, 8:20:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to KMTS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 29.58. This target is 9.88% above the current price.
  • KMTS was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about KMTS.
  • In the previous month the buy percentage consensus was at a similar level.
  • KMTS was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
KMTS Historical Analyst RatingsKMTS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 26.9224.2430.6029.5833.60 - -9.96% 13.67% 9.88% 24.81%

Related screens

Find peers 30% below price target
KMTS Current Analyst RatingKMTS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-12-15 Goldman Sachs Maintains Neutral -> Neutral
2025-12-12 Wells Fargo Maintains Overweight -> Overweight
2025-12-12 Piper Sandler Maintains Overweight -> Overweight
2025-11-18 BTIG Initiate Buy
2025-07-17 Wells Fargo Maintains Overweight -> Overweight
2025-04-16 Goldman Sachs Maintains Neutral -> Neutral
2025-03-31 Wolfe Research Initiate Outperform
2025-03-31 Stifel Initiate Buy
2025-03-31 Wells Fargo Initiate Overweight
2025-03-31 Goldman Sachs Initiate Neutral
2025-03-31 Piper Sandler Initiate Overweight

KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ

What is the average price target for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?

13 analysts have analysed KMTS and the average price target is 29.58 USD. This implies a price increase of 9.88% is expected in the next year compared to the current price of 26.92.


What is the consensus rating for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?

The consensus rating for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed KESTRA MEDICAL TECHNOLOGIES (KMTS)?

The number of analysts covering KESTRA MEDICAL TECHNOLOGIES (KMTS) is 13.